CompletedNot applicableNCT00569023

Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene

Studying Congenital stationary night blindness

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sheba Medical Center
Principal Investigator: Ygal Rotenstreich, MD, APRN, BC
Sheba Medical Center
Intervention: alga Dunaliella bardawil(dietary_supplement)
Enrollment: 7 enrolled
Eligibility: 18-75 years · All sexes
Timeline: 2007 – 2010

Study locations (1)

Sheba Medical Center, Tel Litwinsky, Israel

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00569023 on ClinicalTrials.gov

← Back to all trials